Enveric Biosciences, Inc.
NASDAQ: ENVB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph Edward Tucker
- Employees
- 5
- Headquarters
- Naples, United States
- IPO year
- 2015
- Market cap
- $782.1K
- Website
- https://www.enveric.com
Loading ENVB…
Loading profile data…Frequently asked questions about ENVB
What does Enveric Biosciences, Inc. (ENVB) do?
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is und...
Where does ENVB trade?
Enveric Biosciences, Inc. (ENVB) trades on the NASDAQ Capital Market.
What sector is ENVB in?
Enveric Biosciences, Inc. (ENVB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Enveric Biosciences, Inc.?
Joseph Edward Tucker is the chief executive officer of Enveric Biosciences, Inc. (ENVB).
Where is Enveric Biosciences, Inc. headquartered?
Enveric Biosciences, Inc. is headquartered in United States.
Does ENVB pay a dividend?
Enveric Biosciences, Inc. (ENVB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ENVB go public?
Enveric Biosciences, Inc. (ENVB) completed its initial public offering in 2015.